Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for myocardial angiogenesis.

D W Losordo1, P R Vale, J M Isner

  • 1St. Elizabeth's Medical Center, 736 Cambridge Street, Boston, MA 02135, USA.

American Heart Journal
|July 30, 1999
PubMed
Summary

Gene therapy using vascular endothelial growth factor (VEGF) shows promise for treating chronic myocardial ischemia when traditional methods fail. Intramyocardial gene transfer safely promotes therapeutic angiogenesis, improving symptoms and heart function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis.

Internal medicine journal·2016
Same author

Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia.

Gene therapy·2015
Same author

Persistently increased expression of the transforming growth factor-β1 gene in human vascular restenosis: Analysis of 62 patients with one or more episode of restenosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Same author

Thromboprophylaxis in patients undergoing total hip and knee arthroplasty: a review of current practices in an Australian teaching hospital.

Internal medicine journal·2014
Same author

Evaluation of angiogenesis.

Methods in molecular medicine·2011
Same author

Use of human tissue specimens obtained by directional atherectomy to study restenosis.

Trends in cardiovascular medicine·2011

Area of Science:

  • Cardiovascular Medicine
  • Gene Therapy
  • Regenerative Medicine

Background:

  • Standard treatments like antianginal medications, angioplasty, and bypass surgery are insufficient for some patients with coronary artery disease.
  • Diffuse coronary artery disease or graft occlusion limits revascularization options, leaving patients with limited therapeutic choices.
  • Therapeutic angiogenesis, promoting new blood vessel growth, offers a potential alternative for extensive tissue ischemia.

Purpose of the Study:

  • To evaluate the safety and efficacy of intramyocardial gene transfer of vascular endothelial growth factor (VEGF) for treating chronic myocardial ischemia.
  • To determine if direct gene delivery can induce therapeutic angiogenesis in a porcine model of myocardial ischemia.
  • To assess clinical improvements and myocardial perfusion following gene therapy.

Related Experiment Videos

Main Methods:

  • Utilized a porcine model of chronic myocardial ischemia.
  • Administered direct intramyocardial gene transfer using naked plasmid DNA encoding VEGF (phVEGF(165)) via a minimally invasive chest wall incision.
  • Assessed therapeutic angiogenesis through clinical symptom evaluation and myocardial perfusion imaging (single-photon emission computed tomography-sestamibi).

Main Results:

  • Direct intramyocardial gene transfer of phVEGF(165) was safely and successfully achieved.
  • The procedure promoted therapeutic angiogenesis, leading to clinical improvement in patient symptoms.
  • Enhanced myocardial perfusion was observed, as evidenced by imaging studies.

Conclusions:

  • Intramyocardial gene transfer of VEGF represents a safe and effective strategy for inducing therapeutic angiogenesis in chronic myocardial ischemia.
  • This gene therapy approach offers a viable alternative for patients ineligible for or unresponsive to conventional treatments.
  • Further clinical studies are warranted to confirm these findings and explore broader applications.